Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Force Spectroscopy by Atomic Force Microscopy as Indicator for Cellular Microplastic Uptake.

International journal of molecular sciences·2026
Same author

Hype vs. Health: How Approved Nanomedicines Have Met (or Missed) Early Predictions.

Nanomaterials (Basel, Switzerland)·2026
Same author

Role of atomic force microscopy in characterization of heterotypic cancer spheroids and their interaction with microplastic particles.

Scientific reports·2026
Same author

[Thyroglobulin - An important tumor marker and laboratory challenge].

Deutsche medizinische Wochenschrift (1946)·2026
Same author

Brepocitinib, a selective TYK2/JAK1 inhibitor, mitigates neutrophilic inflammation and glucocorticoid receptor-β expression in COPD.

American journal of physiology. Lung cellular and molecular physiology·2026
Same author

The Effects of Obesity on Lung Physiology, the Prevalence and Severity of Chronic Pulmonary Diseases, and Inhalation Treatment.

Drug design, development and therapy·2026

Related Experiment Video

Updated: Jun 4, 2026

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
03:23

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis

Published on: May 10, 2024

EP4 receptor stimulation down-regulates human eosinophil function.

Petra Luschnig-Schratl1, Eva M Sturm, Viktoria Konya

  • 1Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Universitaetsplatz 4, 8010 Graz, Austria.

Cellular and Molecular Life Sciences : CMLS
|March 3, 2011
PubMed
Summary

A selective EP4 receptor agonist, ONO AE1-329, effectively reduced eosinophil migration and key inflammatory responses in allergic inflammation. This suggests potential new therapies for eosinophil-driven diseases.

More Related Videos

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro
10:36

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro

Published on: January 9, 2018

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
08:44

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Published on: May 30, 2020

Related Experiment Videos

Last Updated: Jun 4, 2026

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
03:23

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis

Published on: May 10, 2024

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro
10:36

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro

Published on: January 9, 2018

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
08:44

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Published on: May 30, 2020

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • Eosinophil accumulation in tissues is a key feature of allergic inflammation.
  • Prostaglandin E2 (PGE2) signaling pathways are implicated in inflammatory processes.

Purpose of the Study:

  • To investigate the effect of a selective prostaglandin E2 receptor EP4 agonist (ONO AE1-329) on human eosinophil functions.
  • To explore the therapeutic potential of EP4 receptor modulation in eosinophilic diseases.

Main Methods:

  • Utilized a selective EP4 receptor agonist (ONO AE1-329) and antagonist.
  • Assessed eosinophil chemotaxis, CD11b upregulation, reactive oxygen species production, and cytoskeletal rearrangement.
  • Investigated the role of PI 3-kinase, PKC, and cAMP signaling pathways.
  • Confirmed EP4 receptor expression on human eosinophils and infiltrating leukocytes.

Main Results:

  • ONO AE1-329 significantly inhibited eosinophil chemotaxis, CD11b expression, and reactive oxygen species production.
  • Inhibition of cytoskeletal rearrangement and calcium (Ca2+) mobilization was observed.
  • EP4 receptor antagonism reversed the inhibitory effects.
  • EP4-mediated inhibition of eosinophil migration was dependent on PI 3-kinase and PKC activation.

Conclusions:

  • EP4 receptor agonists demonstrate potent inhibitory effects on key eosinophil functions relevant to allergic inflammation.
  • EP4 receptors are expressed on human eosinophils and leukocytes in inflamed nasal mucosa.
  • EP4 agonists represent a promising novel therapeutic strategy for managing eosinophilic diseases.